Ocular diseases in patients with rheumatic diseases

Journal of the Medical Association of Thailand

Volumn 85, Issue 8, 2002, Pages 855-862

  Ausayakhun, Somsanguan ^a   Louthrenoo, Worawit ^a   Aupapong, Soontaree ^a  

^a Faculty of Medicine Chiang Mai University   (Thailand)

Author keywords

Cataract; Dry Eye; Glaucoma; Retinopathy; Rheumatic Disease; Uveitis

Indexed keywords

CHLOROQUINE; CORTICOSTEROID;

ADOLESCENT; ADULT; AGED; ARTICLE; CATARACT; COLOR VISION DEFECT; CONTROLLED STUDY; CORNEA DISEASE; DRY EYE; EYE DISEASE; FEMALE; GLAUCOMA; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; MAJOR CLINICAL STUDY; MALE; MIXED CONNECTIVE TISSUE DISEASE; POLYMYOSITIS; RETINOPATHY; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; UVEITIS; VISUAL FIELD DEFECT;

ADOLESCENT; ADULT; AGED; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; EYE DISEASES; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RHEUMATIC DISEASES; THAILAND;

EID: 0036703053     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Williamson J. Incidence of eye disease in cases of connective tissue disease. Trans Ophthal Soc UK 1974; 94: 742-5.
2. Foster CS, Forstot SL, Wilson LA. Mortality rate in rheumatoid arthritis patients developing necrotizing scleritis or peripheral ulcerative keratitis. Ophthalmology 1984; 91: 1253-63.
3. Hobbs H, Sorsby A, Freedman A. Retinopathy following chloroquine therapy. Lancet 1959; 2: 478-80.
4. Nylander U. Ocular damage in chloroquine therapy. Acta Opthalmol 1966; 44: 355-48.
5. Easterbrook M. Ocular effects and safety of antimalarial agents. Am J Med 1988; 85 (Suppl 4 A): 23-9.
6. Easterbrook M. The use of Amsler grids in early chloroquine retinopathy. Ophthalmology 1984; 91: 1368-72.
7. Easterbrook M. Is corneal deposition of antimalarials any indication of retinal toxicity? Can J Ophthalmol 1990; 25: 249-56.
8. Norn MS. Lissamine green. Vital staining of cornea and conjunctiva. Acta Opthalmol 1973; 51: 483-91.
9. van Bijsterveld OP. Diagnostic tests in sicca syndrome. Arch Ophthalmol 1969; 82: 10-4.
10. Lemp MA. Report of the National Eye Institute/ Industry Workshop on clinical trials in dry eyes. CLAO J 1995; 21: 221-31.
11. Coll J, River A, Grino MC, et al. Prevalence of Sjogren's syndrome in autoimmune diseases. Ann Rheum Dis 1987; 46: 286-9.
12. Thompson M, Eadie S. Keratoconjunctivitis sicca and rheumatoid arthritis. Ann Rheum Dis 1956; 5: 21-6.
13. Mody GM, Hill JC, Meyers O. Keratoconjunctivitis sicca in rheumatoid arthritis. Clin Rheumatol 1988; 7: 237-41.
14. Sjogren H. Some problems concerning keratoconjunctivitis sicca syndrome. Acta Ophthalmol 1951; 29: 33-5.
15. Andonopoulos AP, Drosos AA, Skopouli FN, et al. Secondary Sjogren's syndrome in rheumatoid arthritis. J Rheumatol 1987; 14: 1098-103.
16. Grennan DM, Forrester J. Involvement of the eye in SLE and scleroderma. Ann Rheum Dis 1977; 36: 152-6.
17. Alarcon-Segoria D, Ibanez G, Velazquez-Foreo F, et al. Sjogren's syndrome in systemic lupus erythe matosus. Ann Intern Med 1974; 81: 577-83.
18. Andonopoulos AP, Skopouli FN, Dimou GS, et al. Sjogren's syndrome in systemic lupus erythematosus. J Rheumatol 1990; 17: 201-4.
19. Spaeth GL. Corneal staining in systemic lupus erythematosus. N Engl J Med 1967; 276: 1168-71.
20. West RH, Barnett AJ. Ocular involvement in scleroderma. Br J Ophthalmol 1979; 63: 845-7.
21. Horan EC Ophthalmic manifestation in progressive systemic sclerosis. Br J Ophthalmol 1969; 53: 388-92.
22. Alarcon-Segoria D. Symptomatic Sjogren's syndrome in mixed connective tissue disease. J Rheumatol 1976; 3: 191-5.
23. West SK, Valmadrid CT. Epidemiology of risk factors for age related cataract. Surv Ophthalmol 1995; 39: 323-34.
24. Livingston PM, Carson CA, Taylor HR. The epidemiology of cataract : A review of the literature. Ophthalmic Epidemiol 1995; 2: 151-64.
25. Harding JJ. Cataract : Biochemistry, epidemiology and pharmacology. London: Chapman & Hall, 1991.
26. Fournier C, Milot JA, Clermont MJ, O'Regan S. The concept of corticosteroicl cataractogenic factor revisited. Can J Ophthalmol 1990; 25: 345-7.
27. Goldberg I. Specific types of glaucoma : Ocular inflammatory and corticosteroid-induced glaucoma. In : Yanoff M, Duker JJ, eds. Ophthalmology vol 12. London: Mosby, 1999: 12.17.2.
28. Armaly MA. Corticosteroid glaucoma. In : Cairns JE, ed. Glaucoma. London: Grune & Stratton, 1986; 697-710.
29. Scherbal AL. Use of synthetic antimalarial drugs and other agents for rheumatoid arthritis: Historic and therapeutic perspectives. Am J Med 1983; 75 : 1-4.
30. Hobbs H, Calnan C. The ocular complications of chloroquine therapy. Lancet 1958; 1: 1207-9.
31. Hobbs H, Eadie S, Somerville F. Ocular lesion after treatment with chloroquine. Br J Ophthalmol 1961; 45: 284-97.
32. Cambioggi A. Unusual ocular lesions in a case of systemic lupus erythematosus. Arch Opthalmol 1957; 57: 451-3.
33. Hart WM Jr, Burde RM, Johnston GP, Drews RC. Static perimetry in chloroquine retinopathy. Arch Ophthalmol 1984; 102: 377-80.
34. Easterbrook M, Trope G. Visual field testing in detection of early chloroquine retinopathy. In : Proceeding of the annual meeting of the Association for Research in Vision and Ophthalmology, Sarasota, FL, May 5, 1988.
35. Nozik RA, Weinstock F, Vignos P Jr. Ocular complications of chloroquine. Am J Ophthalmol 1964; 58: 774-8.
36. Easterbrook M. Detection and prevention of maculopathy associated with antimalarial agents. Int Ophthalmol Clin 1999; 39: 49-57.
37. Easterbrook M. The sensitivity of Amsler grid testing in early chloroquine retinopathy. Trans Ophthalmol Soc UK 1985; 104: 204-7.
38. Weinberg DV. Trauma : Toxic retinopathies. In Yanotf M, Duker JS, eds. Ophthalmology vol 8. London: Mosby, 1999: 8.46.1.
39. Scherbel AL, Mackenzie AH, Nousek JE, Atdjian M. Ocular lesion in rheumatoid arthritis and related disorders with particular reference to retinopathy. A study of 741 patients treated with and without chloroquine drugs. N Engl J Med 1965; 273: 360-6.
40. Mackenzie AH. Dose refinements in long-term therapy of rheumatoid arthritis with antimalaria. Am J Med 1983; 75: 40-5.
41. Akduman L, Kaplan HJ, Tychsen L. Prevalence of uveitis in an outpatient juvenile arthritis clinic: Onset of uveitis more than a decade after onset of arthritis. J Pediatr Ophthalmol Strabismus 1997; 34: 101-6.
42. Chalom EC, Goldsmith DP, Koehler MA, et al. Prevalence and outcome of uveitis in a regional cohort of patients with juvenile rheumatoid arthritis. J Rhematol 1997; 24: 2031-4.